Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

Ross AL, Bråve A, Scarlatti G, Manrique A, Buonaguro L.

Lancet Infect Dis. 2010 May;10(5):305-16. doi: 10.1016/S1473-3099(10)70069-4.

PMID:
20417413
2.

A brief history of the global effort to develop a preventive HIV vaccine.

Esparza J.

Vaccine. 2013 Aug 2;31(35):3502-18. doi: 10.1016/j.vaccine.2013.05.018. Epub 2013 May 21. Review.

3.

HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem.

Koff WC.

Vaccine. 2012 Jun 19;30(29):4310-5. doi: 10.1016/j.vaccine.2011.11.014. Epub 2011 Nov 17. Review.

PMID:
22100891
4.

Update on progress in HIV vaccine development.

Watkins DI.

Top Antivir Med. 2012 Jun-Jul;20(2):30-1. Review.

5.

A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.

Ferrantelli F, Maggiorella MT, Schiavoni I, Sernicola L, Olivieri E, Farcomeni S, Pavone-Cossut MR, Moretti S, Belli R, Collacchi B, Srivastava IK, Titti F, Cafaro A, Barnett SW, Ensoli B.

Vaccine. 2011 Apr 5;29(16):2918-32. doi: 10.1016/j.vaccine.2011.02.006. Epub 2011 Feb 21.

PMID:
21338681
6.

Current world literature.

[No authors listed]

Curr Opin HIV AIDS. 2009 Sep;4(5):453-7. doi: 10.1097/COH.0b013e3283306278. No abstract available.

PMID:
20046137
7.

Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.

Verkoczy L, Kelsoe G, Moody MA, Haynes BF.

Curr Opin Immunol. 2011 Jun;23(3):383-90. doi: 10.1016/j.coi.2011.04.003. Epub 2011 Apr 27. Review.

8.

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines.

Koff WC, Russell ND, Walport M, Feinberg MB, Shiver JW, Karim SA, Walker BD, McGlynn MG, Nweneka CV, Nabel GJ.

Vaccine. 2013 Apr 18;31 Suppl 2:B204-8. doi: 10.1016/j.vaccine.2012.10.115. Review.

PMID:
23598483
9.

Modulation of HIV-1 immunity by adjuvants.

Moody MA.

Curr Opin HIV AIDS. 2014 May;9(3):242-9. doi: 10.1097/COH.0000000000000052. Review.

10.

Role of neutralizing antibodies in protective immunity against HIV.

Srivastava IK, Ulmer JB, Barnett SW.

Hum Vaccin. 2005 Mar-Apr;1(2):45-60. Epub 2005 Mar 17. Review.

PMID:
17038830
11.

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.

Page M, Stebbings R, Berry N, Hull R, Ferguson D, Davis L, Duffy L, Elsley W, Hall J, Ham C, Hassall M, Li B, Mee ET, Quartey-Papafio R, Rose NJ, Mathy N, Voss G, Stott EJ, Almond N.

Retrovirology. 2012 Jul 16;9:56. doi: 10.1186/1742-4690-9-56.

12.

Vaccine adjuvants: a priority for vaccine research.

Harandi AM, Medaglini D, Shattock RJ; Working Group convened by EUROPRISE.

Vaccine. 2010 Mar 11;28(12):2363-6. doi: 10.1016/j.vaccine.2009.12.084. Epub 2010 Jan 9.

PMID:
20064476
13.

Challenges and opportunities for development of an AIDS vaccine.

Nabel GJ.

Nature. 2001 Apr 19;410(6831):1002-7. Review.

PMID:
11309631
14.

Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012.

Girard MP, Picot V, Longuet C, Nabel GJ.

Vaccine. 2013 Jun 24;31(29):2979-83. doi: 10.1016/j.vaccine.2013.02.068. Epub 2013 Mar 13.

PMID:
23499518
15.

Novel vaccines and adjuvants.

Buonaguro L.

Curr HIV Res. 2010 Jun;8(4):273. No abstract available.

PMID:
20462398
16.

Infectious disease. An enterprising time for HIV vaccine research.

Cohen J.

Science. 2012 Sep 21;337(6101):1446. No abstract available. Erratum in: Science. 2012 Nov 9;338(6108):742.

PMID:
22997300
17.

Broadly neutralizing antibodies and their significance for HIV-1 vaccines.

González N, Alvarez A, Alcamí J.

Curr HIV Res. 2010 Dec;8(8):602-12. Review.

PMID:
21054253
18.

HIV vaccine development--improving on natural immunity.

Johnston MI, Fauci AS.

N Engl J Med. 2011 Sep 8;365(10):873-5. doi: 10.1056/NEJMp1107621. No abstract available.

19.

HIV vaccine: hopes and hurdles.

Chhatbar C, Mishra R, Kumar A, Singh SK.

Drug Discov Today. 2011 Nov;16(21-22):948-56. doi: 10.1016/j.drudis.2011.08.013. Epub 2011 Aug 26. Review.

PMID:
21889604
20.

Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.

Caputo A, Brocca-Cofano E, Castaldello A, Voltan R, Gavioli R, Srivastava IK, Barnett SW, Cafaro A, Ensoli B.

Vaccine. 2008 Feb 26;26(9):1214-27. doi: 10.1016/j.vaccine.2007.12.030. Epub 2008 Jan 15.

PMID:
18243435

Supplemental Content

Support Center